Fc Receptors in Mucosal Immunology

Mucosal Immunology: Fourth Edition

Volumn 1-2, Issue , 2015, Pages 409-428

  van Egmond, Marjolein ^a   Bakema, Jantine E ^b   Woof, Jenny M ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

CD89; Fc receptors; FcRn; Immunoglobulin A; Leukocytes

Indexed keywords

EID: 84939547745     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-415847-4.00020-3     Document Type: Chapter

References (233)

1. Abi-Rached L., Dorighi K., Norman P.J., Yawata M., Parham P. Episodes of natural selection shaped the interactions of IgA-Fc with FcalphaRI and bacterial decoy proteins. J. Immunol. 2007, 178:7943-7954.
2. Abu-Ghazaleh R.I., Fujisawa T., Mestecky J., Kyle R.A., Gleich G.J. IgA-induced eosinophil degranulation. J. Immunol. 1989, 142:2393-2400.
3. Aicher W.K., McGhee M.L., McGhee J.R., Eldridge J.H., Beagley K.W., Meyer T.F., Kiyono H. Mouse IgA Fc receptor on CD3+ T cells. Molecular forms of IgA that bind to a 38-kDa Fc alpha R protein and development of an anti-Fc alpha R antisera. J. Immunol. 1990, 145:1745-1753.
4. Aicher W.K., McGhee M.L., McGhee J.R., Moldoveanu Z., Kidd V.J., Tomana M., Mestecky J., Eldridge J.H., Meyer T.F., Kiyono H. Properties of IgA-binding receptors on murine T cells: relative importance of Fc alpha R, beta-galactosyltransferase and anti-secretory component reactive proteins (ASCP). Scand. J. Immunol. 1992, 35:469-486.
5. Asano M., Komiyama K. Polymeric immunoglobulin receptor. J. Oral Sci. 2011, 53:147-156.
6. Bai Y., Ye L., Tesar D.B., Song H., Zhao D., Bjorkman P.J., Roopenian D.C., Zhu X. Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:18406-18411.
7. Bakema J.E., Bakker A., de Haij S., Honing H., Bracke M., Koenderman L., Vidarsson G., van de Winkel J.G., Leusen J.H. Inside-out regulation of Fc alpha RI (CD89) depends on PP2A. J. Immunol. 2008, 181:4080-4088.
8. Bakema J.E., de Haij S., den Hartog-Jager C.F., Bakker J., Vidarsson G., van Egmond M., van de Winkel J.G., Leusen J.H. Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction. J. Immunol. 2006, 176:3603-3610.
9. Bakema J.E., Hiemstra I.H., Bakker J., de Haij S., Kok Y., Adema G., van Egmond M., Coffer P.J., van de Winkel J.G., Leusen J.H. c-Jun activating binding protein 1 binds to the IgA receptor and modulates protein levels of FcalphaRI and FcRgamma-chain. Eur. J. Immunol. 2010, 40:2035-2040.
10. Bakema J.E., van Egmond M. The human immunoglobulin A Fc receptor FcalphaRI: a multifaceted regulator of mucosal immunity. Mucosal Immunol. 2011, 4:612-624.
11. Bakema J.E., van Egmond M. Immunoglobulin A: a next generation of therapeutic antibodies?. mAbs 2011, 3:352-361.
12. Balu S., Reljic R., Lewis M.J., Pleass R.J., McIntosh R., van Kooten C., van Egmond M., Challacombe S., Woof J.M., Ivanyi J. A novel human IgA monoclonal antibody protects against tuberculosis. J. Immunol. 2011, 186:3113-3119.
13. Bannert C., Bidmon-Fliegenschnee B., Stary G., Hotzy F., Stift J., Nurko S., Szepfalusi Z., Fiebiger E., Dehlink E. Fc-epsilon-RI, the high affinity IgE-receptor, is robustly expressed in the upper gastrointestinal tract and modulated by mucosal inflammation. PLoS One 2012, 7:e42066.
14. Bartemes K.R., Cooper K.M., Drain K.L., Kita H. Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions. J. Allergy Clin. Immunol. 2005, 116:827-835.
15. Baumann J., Park C.G., Mantis N.J. Recognition of secretory IgA by DC-SIGN: implications for immune surveillance in the intestine. Immunol. Lett. 2010, 131:59-66.
16. Ben Mkaddem S., Rossato E., Heming N., Monteiro R.C. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives. Autoimmun. Rev. 2013, 12:666-669.
17. Berthelot L., Papista C., Maciel T.T., Biarnes-Pelicot M., Tissandie E., Wang P.H., Tamouza H., Jamin A., Bex-Coudrat J., Gestin A., Boumediene A., Arcos-Fajardo M., England P., Pillebout E., Walker F., Daugas E., Vrtosvnik F., Flamant M., Benhamou M., Cogne M., Moura I.C., Monteiro R.C. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J. Exp. Med. 2012, 209:793-806.
18. Blank U., Launay P., Benhamou M., Monteiro R.C. Inhibitory ITAMs as novel regulators of immunity. Immunol. Rev. 2009, 232:59-71.
19. Bomsel M., Tudor D., Drillet A.S., Alfsen A., Ganor Y., Roger M.G., Mouz N., Amacker M., Chalifour A., Diomede L., Devillier G., Cong Z., Wei Q., Gao H., Qin C., Yang G.B., Zurbriggen R., Lopalco L., Fleury S. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 2011, 34:269-280.
20. Bracke M., Dubois G.R., Bolt K., Bruijnzeel P.L., Vaerman J.P., Lammers J.W., Koenderman L. Differential effects of the T helper cell type 2-derived cytokines IL-4 and IL-5 on ligand binding to IgG and IgA receptors expressed by human eosinophils. J. Immunol. 1997, 159:1459-1465.
21. Bracke M., Lammers J.W., Coffer P.J., Koenderman L. Cytokine-induced inside-out activation of FcalphaR (CD89) is mediated by a single serine residue (S263) in the intracellular domain of the receptor. Blood 2001, 97:3478-3483.
22. Broen J.C., Coenen M.J., Rueda B., Witte T., Padyukov L., Klareskog L., Hesselstrand R., Wuttge D.M., Simeon C., Ortego-Centeno N., Gonzalez-Gay M.A., Pros A., Hunzelman N., Riemekasten G., Kreuter A., Vonk M., Scorza R., Beretta L., Airo P., van Riel P.L., Kimberly R., Martin J., Edberg J., Radstake T.R. The functional polymorphism 844 A>G in FcalphaRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility. J. Rheumatol. 2011, 38:446-449.
23. Burmeister W.P., Gastinel L.N., Simister N.E., Blum M.L., Bjorkman P.J. Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature 1994, 372:336-343.
24. Burmeister W.P., Huber A.H., Bjorkman P.J. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 1994, 372:379-383.
25. Burton D.R., Woof J.M. Human antibody effector function. Adv. Immunol. 1992, 51:1-84.
26. Carayannopoulos L., Hexham J.M., Capra J.D. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1. J. Exp. Med. 1996, 183:1579-1586.
27. Cauza K., Hinterhuber G., Dingelmaier-Hovorka R., Brugger K., Klosner G., Horvat R., WolffK., Foedinger D. Expression of FcRn, the MHC class I-related receptor for IgG, in human keratinocytes. J. Invest. Dermatol. 2005, 124:132-139.
28. Cerutti A., Puga I., Magri G. The B cell helper side of neutrophils. J. Leuko. Biol 2013, epub Apr 29.
29. Chapman T.L., Heikema A.P., West A.P., Bjorkman P.J. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 2000, 13:727-736.
30. Chen Y.W., Lang M.L., Wade W.F. Protein kinase C-alpha and -delta are required for FcalphaR (CD89) trafficking to MHC class II compartments and FcalphaR-mediated antigen presentation. Traffic 2004, 5:577-594.
31. Cho Y., Honda S., Yoshizawa Y., Takagaki K., Usui K., Shibuya A. Requirement of the cytoplasmic portion for dimer formation of Fcalpha/micro receptor expressed on cell surface. Mol. Immunol. 2010, 47:878-882.
32. Cho Y., Usui K., Honda S., Tahara-Hanaoka S., Shibuya K., Shibuya A. Molecular characteristics of IgA and IgM Fc binding to the Fcalpha/muR. Biochem. Biophys. Res. Commun. 2006, 345:474-478.
33. Cianga P., Cianga C., Cozma L., Ward E.S., Carasevici E. The MHC class I related Fc receptor, FcRn, is expressed in the epithelial cells of the human mammary gland. Hum. Immunol. 2003, 64:1152-1159.
34. Collawn J.F., Stangel M., Kuhn L.A., Esekogwu V., Jing S.Q., Trowbridge I.S., Tainer J.A. Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis. Cell 1990, 63:1061-1072.
35. Coulon S., Dussiot M., Grapton D., Maciel T.T., Wang P.H., Callens C., Tiwari M.K., Agarwal S., Fricot A., Vandekerckhove J., Tamouza H., Zermati Y., Ribeil J.A., Djedaini K., Oruc Z., Pascal V., Courtois G., Arnulf B., Alyanakian M.A., Mayeux P., Leanderson T., Benhamou M., Cogne M., Monteiro R.C., Hermine O., Moura I.C. Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia. Nat. Med. 2011, 17:1456-1465.
36. Daeron M. Fc receptor biology. Annu. Rev. Immunol. 1997, 15:203-234.
37. Daha M.R., van Kooten C. Deposition of IgA in primary IgA nephropathy: it takes at least four to tango. Nephrol. Dial. Transpl. 2012, 28:794-797.
38. Daniels T.R., Delgado T., Rodriguez J.A., Helguera G., Penichet M.L. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. Immunol. 2006, 121:144-158.
39. Dechant M., Beyer T., Schneider-Merck T., Weisner W., Peipp M., van de Winkel J.G., Valerius T. Effector mechanisms of recombinant IgA antibodies against epidermal growth factor receptor. J. Immunol. 2007, 179:2936-2943.
40. Dechant M., Valerius T. IgA antibodies for cancer therapy. Crit. Rev. Oncol. Hematol. 2001, 39:69-77.
41. Dechant M., Vidarsson G., Stockmeyer B., Repp R., Glennie M.J., Gramatzki M., van De Winkel J.G., Valerius T. Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing. Blood 2002, 100:4574-4580.
42. Deo Y.M., Sundarapandiyan K., Keler T., Wallace P.K., Graziano R.F. Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood. J. Immunol. 1998, 160:1677-1686.
43. de Wit T.P., Morton H.C., Capel P.J., van de Winkel J.G. Structure of the gene for the human myeloid IgA Fc receptor (CD89). J. Immunol. 1995, 155:1203-1209.
44. Ding Y., Xu G., Yang M., Yao M., Gao G.F., Wang L., Zhang W., Rao Z. Crystal structure of the ectodomain of human FcalphaRI. J. Biol. Chem. 2003, 278:27966-27970.
45. Duval M., Posner M.R., Cavacini L.A. A bispecific antibody composed of a nonneutralizing antibody to the gp41 immunodominant region and an anti-CD89 antibody directs broad human immunodeficiency virus destruction by neutrophils. J. Virol. 2008, 82:4671-4674.
46. Elm C., Braathen R., Bergmann S., Frank R., Vaerman J.P., Kaetzel C.S., Chhatwal G.S., Johansen F.E., Hammerschmidt S. Ectodomains 3 and 4 of human polymeric immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J. Biol. Chem. 2004, 279:6296-6304.
47. Fayette J., Dubois B., Vandenabeele S., Bridon J.M., Vanbervliet B., Durand I., Banchereau J., Caux C., Briere F. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J. Exp. Med. 1997, 185:1909-1918.
48. Feng X., Zhang Y., Xu R., Xie X., Tao L., Gao H., Gao Y., He Z., Wang H. Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages. Atherosclerosis 2010, 208:396-405.
49. Frithz E., Heden L.O., Lindahl G. Extensive sequence homology between IgA receptor and M proteins in Streptococcus pyogenes. Mol. Microbiol. 1989, 3:1111-1119.
50. Garman S.C., Wurzburg B.A., Tarchevskaya S.S., Kinet J.P., Jardetzky T.S. Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha. Nature 2000, 406:259-266.
51. Geissmann F., Launay P., Pasquier B., Lepelletier Y., Leborgne M., Lehuen A., Brousse N., Monteiro R.C. A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes. J. Immunol. 2001, 166:346-352.
52. Ghumra A., Shi J., McIntosh R.S., Rasmussen I.B., Braathen R., Johansen F.E., Sandlie I., Mongini P.K., Areschoug T., Lindahl G., Lewis M.J., Woof J.M., Pleass R.J. Structural requirements for the interaction of human IgM and IgA with the human Fcalpha/mu receptor. Eur. J. Immunol. 2009, 39:1147-1156.
53. Gomes M.M., Wall S.B., Takahashi K., Novak J., Renfrow M.B., Herr A.B. Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding. Biochemistry 2008, 47:11285-11299.
54. Gould H.J., Sutton B.J. IgE in allergy and asthma today. Nat. Rev. Immunol. 2008, 8:205-217.
55. Guettinger Y., Barbin K., Peipp M., Bruenke J., Dechant M., Horner H., Thierschmidt D., Valerius T., Repp R., Fey G.H., Stockmeyer B. A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells. J. Immunol. 2010, 184:1210-1217.
56. Gulle H., Samstag A., Eibl M.M., Wolf H.M. Physical and functional association of Fc alpha R with protein tyrosine kinase Lyn. Blood 1998, 91:383-391.
57. Haddad E., Moura I.C., Arcos-Fajardo M., Macher M.A., Baudouin V., Alberti C., Loirat C., Monteiro R.C., Peuchmaur M. Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schonlein nephritis: association between CD71 expression and IgA deposits. J. Am. Soc. Nephrol. 2003, 14:327-337.
58. Hamburger A.E., West A.P., Bjorkman P.J. Crystal structure of a polymeric immunoglobulin binding fragment of the human polymeric immunoglobulin receptor. Structure 2004, 12:1925-1935.
59. Hammerschmidt S., Talay S.R., Brandtzaeg P., Chhatwal G.S. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 1997, 25:1113-1124.
60. Hammond J.A., Guethlein L.A., Abi-Rached L., Moesta A.K., Parham P. Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptors. J. Immunol. 2009, 182:3618-3627.
61. Hamre R., Farstad I.N., Brandtzaeg P., Morton H.C. Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR gamma chain on myeloid cells in blood and tissue. Scand. Immunol. 2003, 57:506-516.
62. Harris R.L., van den Berg C.W., Bowen D.J. ASGR1 and ASGR2, the genes that encode the asialoglycoprotein receptor (Ashwell receptor), are expressed in peripheral blood monocytes and show interindividual differences in transcript profile. Mol. Biol. Int. 2012, 283974.
63. Haymann J.P., Levraud J.P., Bouet S., Kappes V., Hagege J., Nguyen G., Xu Y., Rondeau E., Sraer J.D. Characterization and localization of the neonatal Fc receptor in adult human kidney. J. Am. Soc. Nephrol. 2000, 11:632-639.
64. Heden L.O., Frithz E., Lindahl G. Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity. Eur. J. Immunol. 1991, 21:1481-1490.
65. Hellwig S.M., van Spriel A.B., Schellekens J.F., Mooi F.R., van de Winkel J.G. Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect. Immun. 2001, 69:4846-4850.
66. Herr A.B., Ballister E.R., Bjorkman P.J. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc. Nature 2003, 423:614-620.
67. Herr A.B., White C.L., Milburn C., Wu C., Bjorkman P.J. Bivalent binding of IgA1 to FcalphaRI suggests a mechanism for cytokine activation of IgA phagocytosis. J. Mol. Biol. 2003, 327:645-657.
68. Hexham J.M., White K.D., Carayannopoulos L.N., Mandecki W., Brisette R., Yang Y.S., Capra J.D. A human immunoglobulin (Ig)A calpha3 domain motif directs polymeric Ig receptor-mediated secretion. J. Exp. Med. 1999, 189:747-752.
69. Heystek H.C., Moulon C., Woltman A.M., Garonne P., van Kooten C. Human immature dendritic cells efficiently bind and take up secretory IgA without the induction of maturation. J. Immunol. 2002, 168:102-107.
70. Holdom M.D., Davies A.M., Nettleship J.E., Bagby S.C., Dhaliwal B., Girardi E., Hunt J., Gould H.J., Beavil A.J., McDonnell J.M., Owens R.J., Sutton B.J. Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcvarepsilonRI. Nat. Struct. Mol. Biol. 2011, 18:571-576.
71. Honda S., Kurita N., Miyamoto A., Cho Y., Usui K., Takeshita K., Takahashi S., Yasui T., Kikutani H., Kinoshita T., Fujita T., Tahara-Hanaoka S., Shibuya K., Shibuya A. Enhanced humoral immune responses against T-independent antigens in Fc alpha/muR-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:11230-11235.
72. Honorio-Franca A.C., Launay P., Carneiro-Sampaio M.M., Monteiro R.C. Colostral neutrophils express Fc alpha receptors (CD89) lacking gamma chain association and mediate noninflammatory properties of secretory IgA. J. Leuko. Bio. 2001, 69:289-296.
73. Huls G., Heijnen I.A., Cuomo E., van der Linden J., Boel E., van de Winkel J.G., Logtenberg T. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies. Cancer Res. 1999, 59:5778-5784.
74. Huls G.A., Heijnen I.A., Cuomo M.E., Koningsberger J.C., Wiegman L., Boel E., van der Vuurst de Vries A.R., Loyson S.A., Helfrich W., van Berge Henegouwen G.P., van Meijer M., de Kruif J., Logtenberg T. A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments. Nat. Biotechnol. 1999, 17:276-281.
75. Iikura M., Yamaguchi M., Fujisawa T., Miyamasu M., Takaishi T., Morita Y., Iwase T., Moro I., Yamamoto K., Hirai K. Secretory IgA induces degranulation of IL-3-primed basophils. J. Immunol. 1998, 161:1510-1515.
76. Israel E.J., Taylor S., Wu Z., Mizoguchi E., Blumberg R.S., Bhan A., Simister N.E. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology 1997, 92:69-74.
77. Jasek M., Manczak M., Sawaryn A., Obojski A., Wisniewski A., Luszczek W., Kusnierczyk P. A novel polymorphism in the cytoplasmic region of the human immunoglobulin A Fc receptor gene. Eur. J. Immunogenet. 2004, 31:59-62.
78. Johansen F.E., Braathen R., Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J. Immunol. 2001, 167:5185-5192.
79. Johansen F.E., Kaetzel C.S. Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Muc. Immunol. 2011, 4:598-602.
80. Kanamaru Y., Blank U., Monteiro R.C. IgA Fc receptor I is a molecular switch that determines IgA activating or inhibitory functions. Contrib. Nephrol. 2007, 157:148-152.
81. Kaneko S., Kobayashi T., Yamamoto K., Jansen M.D., van de Winkel J.G., Yoshie H. A novel polymorphism of FcalphaRI (CD89) associated with aggressive periodontitis. Tissue Antigens 2004, 63:572-577.
82. Keler T., Wallace P.K., Vitale L.A., Russoniello C., Sundarapandiyan K., Graziano R.F., Deo Y.M. Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages. J. Immunol. 2000, 164:5746-5752.
83. Kikuno K., Kang D.W., Tahara K., Torii I., Kubagawa H.M., Ho K.J., Baudino L., Nishizaki N., Shibuya A., Kubagawa H. Unusual biochemical features and follicular dendritic cell expression of human Fcalpha/mu receptor. Eur. J. Immunol. 2007, 37:3540-3550.
84. Kobayashi N., Suzuki Y., Tsuge T., Okumura K., Ra C., Tomino Y. FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells. Am. J. Physiol. Ren. Physiol. 2002, 282:F358-F365.
85. Kobayashi T., Yamamoto K., Sugita N., van Spriel A.B., Kaneko S., van de Winkel J.G., Yoshie H. Effective in vitro clearance of Porphyromonas gingivalis by Fc alpha receptor I (CD89) on gingival crevicular neutrophils. Infect. Immun. 2001, 69:2935-2942.
86. Kremer E.J., Kalatzis V., Baker E., Callen D.F., Sutherland G.R., Maliszewski C.R. The gene for the human IgA Fc receptor maps to 19q13.4. Hum. Genet. 1992, 89:107-108.
87. Kuo T.T., Baker K., Yoshida M., Qiao S.W., Aveson V.G., Lencer W.I., Blumberg R.S. Neonatal Fc receptor: from immunity to therapeutics. J. Clin. Immunol. 2010, 30:777-789.
88. Kurita N., Honda S., Usui K., Shimizu Y., Miyamoto A., Tahara-Hanaoka S., Shibuya K., Shibuya A. Identification of the Fcalpha/muR isoform specifically expressed in the kidney tubules. Mol. Immunol. 2009, 46:749-753.
89. Lamkhioued B., Gounni A.S., Gruart V., Pierce A., Capron A., Capron M. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation. Eur. J. Immunol. 1995, 25:117-125.
90. Lang M.L., Glennie M.J., Kerr M.A. Human neutrophil Fc alpha R and Fc gamma RIIa but not Fc gamma RIIIb generate intracellular calcium signals which trigger the respiratory burst. Biochem. Soc. Trans. 1997, 25:333S.
91. Lang M.L., Kerr M.A. Characterization of FcalphaR-triggered Ca(2+) signals: role in neutrophil NADPH oxidase activation. Biochem. Biophys. Res. Commun. 2000, 276:749-755.
92. Lang M.L., Shen L., Gao H., Cusack W.F., Lang G.A., Wade W.F. Fc alpha receptor cross-linking causes translocation of phosphatidylinositol-dependent protein kinase 1 and protein kinase B alpha to MHC class II peptide-loading-like compartments. J. Immunol. 2001, 166:5585-5593.
93. Lang M.L., Shen L., Wade W.F. Gamma-chain dependent recruitment of tyrosine kinases to membrane rafts by the human IgA receptor Fc alpha R. J. Immunol. 1999, 163:5391-5398.
94. Launay P., Grossetete B., Arcos-Fajardo M., Gaudin E., Torres S.P., Beaudoin L., Patey-Mariaud de Serre N., Lehuen A., Monteiro R.C. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J. Exp. Med. 2000, 191:1999-2009.
95. Launay P., Lehuen A., Kawakami T., Blank U., Monteiro R.C. IgA Fc receptor (CD89) activation enables coupling to syk and Btk tyrosine kinase pathways: differential signaling after IFN-gamma or phorbol ester stimulation. J. Leukoc. Biol. 1998, 63:636-642.
96. Launay P., Patry C., Lehuen A., Pasquier B., Blank U., Monteiro R.C. Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRgamma association and protects against degradation of bound ligand. J. Biol. Chem. 1999, 274:7216-7225.
97. Lebreton C., Menard S., Abed J., Moura I.C., Coppo R., Dugave C., Monteiro R.C., Fricot A., Traore M.G., Griffin M., Cellier C., Malamut G., Cerf-Bensussan N., Heyman M. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology 2012, 143:698-707. e691-694.
98. Lecocq M., Detry B., Guisset A., Pilette C. FcαRI-mediated inhibition of IL-12 production and priming by IFN-γ of human monocytes and dendritic cells. J. Immunol. 2013, 190:2362-2371.
99. Lebron J.A., Bennett M.J., Vaughn D.E., Chirino A.J., Snow P.M., Mintier G.A., Feder J.N., Bjorkman P.J. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998, 93:111-123.
100. Leo J.C., Lyskowski A., Hattula K., Hartmann M.D., Schwarz H., Butcher S.J., Linke D., Lupas A.N., Goldman A. The structure of E. coli IgG-binding protein D suggests a general model for bending and binding in trimeric autotransporter adhesins. Structure 2011, 19:1021-1030.
101. Lewis M.J., Meehan M., Owen P., Woof J.M. A common theme in interaction of bacterial immunoglobulin-binding proteins with immunoglobulins illustrated in the equine system. J. Biol. Chem. 2008, 283:17615-17623.
102. Lewis M.J., Pleass R.J., Batten M.R., Atkin J.D., Woof J.M. Structural requirements for the interaction of human IgA with the human polymeric Ig receptor. J. Immunol. 2005, 175:6694-6701.
103. Li H., Nowak-Wegrzyn A., Charlop-Powers Z., Shreffler W., Chehade M., Thomas S., Roda G., Dahan S., Sperber K., Berin M.C. Transcytosis of IgE-antigen complexes by CD23a in human intestinal epithelial cells and its role in food allergy. Gastroenterology 2006, 131:47-58.
104. Li Z., Palaniyandi S., Zeng R., Tuo W., Roopenian D.C., Zhu X. Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4388-4393.
105. Liu J., Hu B., Yang Y., Ma Z., Yu Y., Liu S., Wang B., Zhao X., Lu M., Yang D. A new splice variant of the major subunit of human asialoglycoprotein receptor encodes a secreted form in hepatocytes. PLoS One 2010, 5:e12934.
106. Lohse S., Peipp M., Beyer T., Valerius T., Dechant M. Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodies. Arch. Immunol. Ther. Exp. Warsz. 2010, 58:303-312.
107. Lu J., Marjon K.D., Marnell L.L., Wang R., Mold C., Du Clos T.W., Sun P. Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4974-4979.
108. Lu J., Marjon K.D., Mold C., Du Clos T.W., Sun P.D. Pentraxins and Fc receptors. Immunol. Rev. 2012, 250:230-238.
109. Lu L., Lamm M.E., Li H., Corthesy B., Zhang J.R. The human polymeric immunoglobulin receptor binds to Streptococcus pneumoniae via domains 3 and 4. J. Biol. Chem. 2003, 278:48178-48187.
110. Maillard N., Thibaudin L., Abadja F., Masson I., Garraud O., Berthoux F., Alamartine E., Mariat C. Single nucleotidic polymorphism 844 A>G of FCAR is not associated with IgA nephropathy in Caucasians. Nephrol. Dial. Transpl. 2012, 27:656-660.
111. Maliszewski C.R., March C.J., Schoenborn M.A., Gimpel S., Shen L. Expression cloning of a human Fc receptor for IgA. J. Exp. Med. 1990, 172:1665-1672.
112. Mantis N.J., Cheung M.C., Chintalacharuvu K.R., Rey J., Corthesy B., Neutra M.R. Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor. J. Immunol. 2002, 169:1844-1851.
113. Martin A.M., Kulski J.K., Witt C., Pontarotti P., Christiansen F.T. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol. 2002, 23:81-88.
114. Martin W.L., West A.P., Gan L., Bjorkman P.J. Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. Mol. Cell. 2001, 7:867-877.
115. Maruoka T., Nagata T., Kasahara M. Identification of the rat IgA Fc receptor encoded in the leukocyte receptor complex. Immunogenetics 2004, 55:712-716.
116. Matesanz-Isabel J., Sintes J., Llinas L., de Salort J., Lazaro A., Engel P. New B-cell CD molecules. Immunol. Lett. 2010, 134:104-112.
117. Mattu T.S., Pleass R.J., Willis A.C., Kilian M., Wormald M.R., Lellouch A.C., Rudd P.M., Woof J.M., Dwek R.A. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions. J. Biol. Chem. 1998, 273:2260-2272.
118. Matysiak-Budnik T., Moura I.C., Arcos-Fajardo M., Lebreton C., Menard S., Candalh C., Ben-Khalifa K., Dugave C., Tamouza H., van Niel G., Bouhnik Y., Lamarque D., Chaussade S., Malamut G., Cellier C., Cerf-Bensussan N., Monteiro R.C., Heyman M. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J. Exp. Med. 2008, 205:143-154.
119. Monteiro R.C., Cooper M.D., Kubagawa H. Molecular heterogeneity of Fc alpha receptors detected by receptor-specific monoclonal antibodies. J. Immunol. 1992, 148:1764-1770.
120. Monteiro R.C., Hostoffer R.W., Cooper M.D., Bonner J.R., Gartland G.L., Kubagawa H. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J. Clin. Invest. 1993, 92:1681-1685.
121. Monteiro R.C., Moura I.C., Launay P., Tsuge T., Haddad E., Benhamou M., Cooper M.D., Arcos-Fajardo M. Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol. Med. 2002, 8:464-468.
122. Monteiro R.C., van de Winkel J.G. IgA Fc receptors. Annu. Rev. Immunol. 2003, 21:177-204.
123. Morton H.C. IgA Fc receptors in cattle and horses. Vet. Immunol. Immunopathol. 2005, 108:139-143.
124. Morton H.C., Pleass R.J., Storset A.K., Brandtzaeg P., Woof J.M. Cloning and characterization of equine CD89 and identification of the CD89 gene in chimpanzees and rhesus macaques. Immunology 2005, 115:74-84.
125. Morton H.C., Pleass R.J., Storset A.K., Dissen E., Williams J.L., Brandtzaeg P., Woof J.M. Cloning and characterization of an immunoglobulin A Fc receptor from cattle. Immunology 2004, 111:204-211.
126. Morton H.C., van den Herik-Oudijk I.E., Vossebeld P., Snijders A., Verhoeven A.J., Capel P.J., van de Winkel J.G. Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR gamma chain. Molecular basis for CD89/FcR gamma chain association. J. Biol. Chem. 1995, 270:29781-29787.
127. Mostov K.E. Transepithelial transport of immunoglobulins. Annu. Rev. Immunol. 1994, 12:63-84.
128. Mota G., Galatiuc C., Popescu I., Hirt M., Cialacu V., Sulica A. IgA monoclonal and polyclonal proteins as regulatory factors of the NK cytotoxic activity. Rom. J. Virol. 1999, 50:17-31.
129. Mota G., Manciulea M., Cosma E., Popescu I., Hirt M., Jensen-Jarolim E., Calugaru A., Galatiuc C., Regalia T., Tamandl D., Spittler A., Boltz-Nitulescu G. Human NK cells express Fc receptors for IgA which mediate signal transduction and target cell killing. Eur. J. Immunol. 2003, 33:2197-2205.
130. Motegi Y., Kita H. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils. J. Immunol. 1998, 161:4340-4346.
131. Moura I.C., Arcos-Fajardo M., Gdoura A., Leroy V., Sadaka C., Mahlaoui N., Lepelletier Y., Vrtovsnik F., Haddad E., Benhamou M., Monteiro R.C. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J. Am. Soc. Nephrol. 2005, 16:2667-2676.
132. Moura I.C., Arcos-Fajardo M., Sadaka C., Leroy V., Benhamou M., Novak J., Vrtovsnik F., Haddad E., Chintalacharuvu K.R., Monteiro R.C. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J. Am. Soc. Nephrol. 2004, 15:622-634.
133. Moura I.C., Centelles M.N., Arcos-Fajardo M., Malheiros D.M., Collawn J.F., Cooper M.D., Monteiro R.C. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J. Exp. Med. 2001, 194:417-425.
134. Nakahara J., Seiwa C., Shibuya A., Aiso S., Asou H. Expression of Fc receptor for immunoglobulin M in oligodendrocytes and myelin of mouse central nervous system. Neurosci. Lett. 2003, 337:73-76.
135. Narita I., Goto S., Saito N., Sakatsume M., Jin S., Omori K., Gejyo F. Genetic polymorphisms in the promoter and 5' UTR region of the Fc alpha receptor (CD89) are not associated with a risk of IgA nephropathy. J. Hum. Genet. 2001, 46:694-698.
136. Nikolova E.B., Russell M.W. Dual function of human IgA antibodies: inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8-stimulated cells. J. Leukoc. Biol. 1995, 57:875-882.
137. Nimmerjahn F., Ravetch J.V. FcgammaRs in health and disease. Curr. Top. Microbiol. Immunol. 2011, 350:105-125.
138. Oortwijn B.D., Roos A., van der Boog P.J., Klar-Mohamad N., van Remoortere A., Deelder A.M., Daha M.R., van Kooten C. Monomeric and polymeric IgA show a similar association with the myeloid FcalphaRI/CD89. Mol. Immunol. 2007, 44:966-973.
139. Otten M.A., Groenveld I., van de Winkel J.G., van Egmond M. Inefficient antigen presentation via the IgA Fc receptor (FcalphaRI) on dendritic cells. Immunobiology 2006, 211:503-510.
140. Otten M.A., Leusen J.H., Rudolph E., van der Linden J.A., Beelen R.H., van de Winkel J.G., van Egmond M. FcR gamma-chain dependent signaling in immature neutrophils is mediated by FcalphaRI, but not by FcgammaRI. J. Immunol. 2007, 179:2918-2924.
141. Otten M.A., Rudolph E., Dechant M., Tuk C.W., Reijmers R.M., Beelen R.H., van de Winkel J.G., van Egmond M. Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors. J. Immunol. 2005, 174:5472-5480.
142. Ouadrhiri Y., Pilette C., Monteiro R.C., Vaerman J.P., Sibille Y. Effect of IgA on respiratory burst and cytokine release by human alveolar macrophages: role of ERK1/2 mitogen-activated protein kinases and NF-kappaB. Am. J. Respir. Cell. Mol. Biol. 2002, 26:315-332.
143. Palaniyandi S., Tomei E., Li Z., Conrad D.H., Zhu X. CD23-dependent transcytosis of IgE and immune complex across the polarized human respiratory epithelial cells. J. Immunol. 2011, 186:3484-3496.
144. Park R.K., Izadi K.D., Deo Y.M., Durden D.L. Role of Src in the modulation of multiple adaptor proteins in FcalphaRI oxidant signaling. Blood 1999, 94:2112-2120.
145. Pasquier B., Launay P., Kanamaru Y., Moura I.C., Pfirsch S., Ruffie C., Henin D., Benhamou M., Pretolani M., Blank U., Monteiro R.C. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 2005, 22:31-42.
146. Pasquier B., Lepelletier Y., Baude C., Hermine O., Monteiro R.C. Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells. J. Leukoc. Biol. 2004, 76:1134-1141.
147. Patry C., Sibille Y., Lehuen A., Monteiro R.C. Identification of Fc alpha receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J. Immunol. 1996, 156:4442-4448.
148. Peng M., Guo S., Yin N., Xue J., Shen L., Zhao Q., Zhang W. Ectodomain shedding of Fcalpha receptor is mediated by ADAM10 and ADAM17. Immunology 2010, 130:83-91.
149. Pfefferkorn L.C., Yeaman G.R. Association of IgA-Fc receptors (Fc alpha R) with Fc epsilon RI gamma 2 subunits in U937 cells. Aggregation induces the tyrosine phosphorylation of gamma 2. J. Immunol. 1994, 153:3228-3236.
150. Pfirsch-Maisonnas S., Aloulou M., Xu T., Claver J., Kanamaru Y., Tiwari M., Launay P., Monteiro R.C., Blank U. Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized "inhibisome" clusters. Sci. Signal 2011, 4:ra24.
151. Pilette C., Detry B., Guisset A., Gabriels J., Sibille Y. Induction of interleukin-10 expression through Fcalpha receptor in human monocytes and monocyte-derived dendritic cells: role of p38 MAPKinase. Immunol. Cell. Biol. 2010, 88:486-493.
152. Pinel-Marie M.L., Louarn L., Desmots S., Fardel O., Sparfel L. Aryl hydrocarbon receptor-dependent induction of the IgA receptor FcalphaRI by the environmental contaminant benzo(a)pyrene in human macrophages. Toxicology 2011, 290:89-95.
153. Pleass R.J., Areschoug T., Lindahl G., Woof J.M. Streptococcal IgA-binding proteins bind in the Calpha 2-Calpha 3 interdomain region and inhibit binding of IgA to human CD89. J. Biol. Chem. 2001, 276:8197-8204.
154. Pleass R.J., Dehal P.K., Lewis M.J., Woof J.M. Limited role of charge matching in the interaction of human immunoglobulin A with the immunoglobulin A Fc receptor (Fc alpha RI) CD89. Immunology 2003, 109:331-335.
155. Pleass R.J., Dunlop J.I., Anderson C.M., Woof J.M. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human fcalpha receptor (FcalphaR) CD89. J. Biol. Chem. 1999, 274:23508-23514.
156. Pleass R.J., Lang M.L., Kerr M.A., Woof J.M. IgA is a more potent inducer of NADPH oxidase activation and degranulation in blood eosinophils than IgE. Mol. Immunol. 2007, 44:1401-1408.
157. Purzel J., Schmitt R., Viertlboeck B.C., Gobel T.W. Chicken IgY binds its receptor at the CH3/CH4 interface similarly as the human IgA: Fc alpha RI interaction. J. Immunol. 2009, 183:4554-4559.
158. Qian K., Xie F., Gibson A.W., Edberg J.C., Kimberly R.P., Wu J. Functional expression of IgA receptor FcalphaRI on human platelets. J. Leuko. Biol. 2008, 84:1492-1500.
159. Qiao S., Yang Y., Liu Y., Zhang G., Xi J., Zhang H., Hao H., Tian X., Yang S., Deng R. Characterization and ligand specificity of sheep IgG2 receptor. Immunogenetics 2009, 61:597-601.
160. Radoshitzky S.R., Abraham J., Spiropoulou C.F., Kuhn J.H., Nguyen D., Li W., Nagel J., Schmidt P.J., Nunberg J.H., Andrews N.C., Farzan M., Choe H. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 2007, 446:92-96.
161. Ramsland P.A., Willoughby N., Trist H.M., Farrugia W., Hogarth P.M., Fraser J.D., Wines B.D. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:15051-15056.
162. Rath T., Kuo T.T., Baker K., Qiao S.W., Kobayashi K., Yoshida M., Roopenian D., Fiebiger E., Lencer W.I., Blumberg R.S. The immunologic functions of the neonatal Fc receptor for IgG. J. Clin. Immunol. 2013, 33:S9-S17.
163. Rogers K.A., Scinicariello F., Attanasio R. Identification and characterization of macaque CD89 (immunoglobulin A Fc receptor). Immunology 2004, 113:178-186.
164. Roopenian D.C., Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat. Rev. Immunol. 2007, 7:715-725.
165. Sakamoto N., Shibuya K., Shimizu Y., Yotsumoto K., Miyabayashi T., Sakano S., Tsuji T., Nakayama E., Nakauchi H., Shibuya A. A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non-hematopoietic tissues. Eur. J. Immunol. 2001, 31:1310-1316.
166. Sandt C.H., Hill C.W. Nonimmune binding of human immunoglobulin A (IgA) and IgG Fc by distinct sequence segments of the EibF cell surface protein of Escherichia coli. Infect. Immun. 2001, 69:7293-7303.
167. Schmidt P.J., Toran P.T., Giannetti A.M., Bjorkman P.J., Andrews N.C. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 2008, 7:205-214.
168. Shen L., Lang M.L., Wade W.F. The ins and outs of getting in: structures and signals that enhance BCR or Fc receptor-mediated antigen presentation. Immunopharmacology 2000, 49:227-240.
169. Shen L., van Egmond M., Siemasko K., Gao H., Wade T., Lang M.L., Clark M., van De Winkel J.G., Wade W.F. Presentation of ovalbumin internalized via the immunoglobulin-A Fc receptor is enhanced through Fc receptor gamma-chain signaling. Blood 2001, 97:205-213.
170. Shibuya A., Sakamoto N., Shimizu Y., Shibuya K., Osawa M., Hiroyama T., Eyre H.J., Sutherland G.R., Endo Y., Fujita T., Miyabayashi T., Sakano S., Tsuji T., Nakayama E., Phillips J.H., Lanier L.L., Nakauchi H. Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. 2000, 1:441-446.
171. Shimizu Y., Honda S., Yotsumoto K., Tahara-Hanaoka S., Eyre H.J., Sutherland G.R., Endo Y., Shibuya K., Koyama A., Nakauchi H., Shibuya A. Fc(alpha)/mu receptor is a single gene-family member closely related to polymeric immunoglobulin receptor encoded on Chromosome 1. Immunogenetics 2001, 53:709-711.
172. Shimokawa T., Ra C. C/EBP alpha and Ets protein family members regulate the human myeloid IgA Fc receptor (Fc alpha R, CD89) promoter. J. Immunol. 2003, 170:2564-2572.
173. Shimokawa T., Ra C. C/EBPalpha functionally and physically interacts with GABP to activate the human myeloid IgA Fc receptor (Fc alphaR, CD89) gene promoter. Blood 2005, 106:2534-2542.
174. Shimokawa T., Tsuge T., Okumura K., Ra C. Identification and characterization of the promoter for the gene encoding the human myeloid IgA Fc receptor (FcalphaR, CD89). Immunogenetics 2000, 51:945-954.
175. Simister N.E. Placental transport of immunoglobulin G. Vaccine 2003, 21:3365-3369.
176. Smith P.D., Smythies L.E., Mosteller-Barnum M., Sibley D.A., Russell M.W., Merger M., Sellers M.T., Orenstein J.M., Shimada T., Graham M.F., Kubagawa H. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J. Immunol. 2001, 167:2651-2656.
177. Snoeck V., Peters I.R., Cox E. The IgA system: a comparison of structure and function in different species. Vet. Res. 2006, 37:455-467.
178. Sondermann P., Huber R., Oosthuizen V., Jacob U. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature 2000, 406:267-273.
179. Spiekermann G.M., Finn P.W., Ward E.S., Dumont J., Dickinson B.L., Blumberg R.S., Lencer W.I. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J. Exp. Med. 2002, 196:303-310.
180. Stadick H., Stockmeyer B., Kuhn R., Schrott K.M., Kalden J.R., Glennie M.J., van de Winkel J.G., Gramatzki M., Valerius T., Elsasser D. Epidermal growth factor receptor and g250: useful target antigens for antibody mediated cellular cytotoxicity against renal cell carcinoma?. J. Urol. 2002, 167:707-712.
181. Stenberg L., O'Toole P.W., Mestecky J., Lindahl G. Molecular characterization of protein Sir, a streptococcal cell surface protein that binds both immunoglobulin A and immunoglobulin G. J. Biol. Chem. 1994, 269:13458-13464.
182. Stewart W.W., Kerr M.A. The specificity of the human neutrophil IgA receptor (Fc alpha R) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2. Immunology 1990, 71:328-334.
183. Stockert R.J. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol. Rev. 1995, 75:591-609.
184. Stockmeyer B., Beyer T., Neuhuber W., Repp R., Kalden J.R., Valerius T., Herrmann M. Polymorphonuclear granulocytes induce antibody-dependent apoptosis in human breast cancer cells. J. Immunol. 2003, 171:5124-5129.
185. Stockmeyer B., Dechant M., van Egmond M., Tutt A.L., Sundarapandiyan K., Graziano R.F., Repp R., Kalden J.R., Gramatzki M., Glennie M.J., van de Winkel J.G., Valerius T. Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy. J. Immunol. 2000, 165:5954-5961.
186. Stockmeyer B., Elsasser D., Dechant M., Repp R., Gramatzki M., Glennie M.J., van de Winkel J.G., Valerius T. Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies. J. Immunol. Methods 2001, 248:103-111.
187. Tamouza H., Chemouny J.M., Raskova Kafkova L., Berthelot L., Flamant M., Demion M., Mesnard L., Paubelle E., Walker F., Julian B.A., Tissandie E., Tiwari M.K., Camara N.O., Vrtovsnik F., Benhamou M., Novak J., Monteiro R.C., Moura I.C. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy. Kidney Int. 2012, 82:1284-1296.
188. Taylor A.I., Beavil R.L., Sutton B.J., Calvert R.A. A monomeric chicken IgY receptor binds IgY with 2:1 stoichiometry. J. Biol. Chem. 2009, 284:24168-24175.
189. Taylor A.I., Sutton B.J., Calvert R.A. Mutations in an avian IgY-Fc fragment reveal the locations of monocyte Fc receptor binding sites. Dev. Comp. Immunol. 2010, 34:97-101.
190. Tsuge T., Shimokawa T., Horikoshi S., Tomino Y., Ra C. Polymorphism in promoter region of Fcalpha receptor gene in patients with IgA nephropathy. Hum. Genet. 2001, 108:128-133.
191. Tu Y., Salim S., Bourgeois J., Di Leo V., Irvine E.J., Marshall J.K., Perdue M.H. CD23-mediated IgE transport across human intestinal epithelium: inhibition by blocking sites of translation or binding. Gastroenterology 2005, 129:928-940.
192. van Bilsen K., van Hagen P.M., Bastiaans J., van Meurs J.C., Missotten T., Kuijpers R.W., Hooijkaas H., Dingjan G.M., Baarsma G.S., Dik W.A. The neonatal Fc receptor is expressed by human retinal pigment epithelial cells and is downregulated by tumour necrosis factor-alpha. Br. J. Ophthalmol. 2011, 95:864-868.
193. van der Pol W., Vidarsson G., Vile H.A., van de Winkel J.G., Rodriguez M.E. Pneumococcal capsular polysaccharide-specific IgA triggers efficient neutrophil effector functions via FcalphaRI (CD89). J. Infect. Dis. 2000, 182:1139-1145.
194. van der Steen L.P., Bakema J.E., Sesarman A., Florea F., Tuk C.W., Kirtschig G., Hage J.J., Sitaru C., van Egmond M. Blocking Fcalpha receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies. J. Immunol. 2012, 189:1594-1601.
195. van der Steen L., Tuk C.W., Bakema J.E., Kooij G., Reijerkerk A., Vidarsson G., Bouma G., Kraal G., de Vries H.E., Beelen R.H., van Egmond M. Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4. Gastroenterology 2009, 137:2018-2029. e2011-2013.
196. van Dijk T.B., Bracke M., Caldenhoven E., Raaijmakers J.A., Lammers J.W., Koenderman L., de Groot R.P. Cloning and characterization of Fc alpha Rb, a novel Fc alpha receptor (CD89) isoform expressed in eosinophils and neutrophils. Blood 1996, 88:4229-4238.
197. van Egmond M., Hanneke van Vuuren A.J., van de Winkel J.G. The human Fc receptor for IgA (Fc alpha RI, CD89) on transgenic peritoneal macrophages triggers phagocytosis and tumor cell lysis. Immunol. Lett. 1999, 68:83-87.
198. van Egmond M., van Garderen E., van Spriel A.B., Damen C.A., van Amersfoort E.S., van Zandbergen G., van Hattum J., Kuiper J., van de Winkel J.G. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat. Med. 2000, 6:680-685.
199. van Egmond M., van Spriel A.B., Vermeulen H., Huls G., van Garderen E., van de Winkel J.G. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89). Cancer Res. 2001, 61:4055-4060.
200. van Egmond M., van Vuuren A.J., Morton H.C., van Spriel A.B., Shen L., Hofhuis F.M., Saito T., Mayadas T.N., Verbeek J.S., van de Winkel J.G. Human immunoglobulin A receptor (FcalphaRI, CD89) function in transgenic mice requires both FcR gamma chain and CR3 (CD11b/CD18). Blood 1999, 93:4387-4394.
201. van Epps D.E., Brown S.L. Inhibition of formylmethionyl-leucyl-phenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins. Infect. Immun. 1981, 34:864-870.
202. van Epps D.E., Reed K., Williams R.C. Suppression of human PMN bactericidal activity by human IgA paraproteins. Cell. Immunol. 1978, 36:363-376.
203. van Epps D.E., Williams R.C. Suppression of leukocyte chemotaxis by human IgA myeloma components. J. Exp. Med. 1976, 144:1227-1242.
204. van Spriel A.B., Leusen J.H., van Egmond M., Dijkman H.B., Assmann K.J., Mayadas T.N., van de Winkel J.G. Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. Blood 2001, 97:2478-2486.
205. van Spriel A.B., van den Herik-Oudijk I.E., van Sorge N.M., Vile H.A., van Strijp J.A., van de Winkel J.G. Effective phagocytosis and killing of Candida albicans via targeting FcgammaRI (CD64) or FcalphaRI (CD89) on neutrophils. J. Infect. Dis. 1999, 179:661-669.
206. van Zandbergen G., Westerhuis R., Mohamad N.K., van De Winkel J.G., Daha M.R., van Kooten C. Crosslinking of the human Fc receptor for IgA (FcalphaRI/CD89) triggers FcR gamma-chain-dependent shedding of soluble CD89. J. Immunol. 1999, 163:5806-5812.
207. Vidarsson, G., 2000. Immunity to Encapsulated Bacteria (thesis). ISBN: 90-393-2402-6.
208. Vidarsson G., Stemerding A.M., Stapleton N.M., SpliethoffS.E., Janssen H., Rebers F.E., de Haas M., van de Winkel J.G. FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis. Blood 2006, 108:3573-3579.
209. Vidarsson G., van Der Pol W.L., van Den Elsen J.M., Vile H., Jansen M., Duijs J., Morton H.C., Boel E., Daha M.R., Corthesy B., van De Winkel J.G. Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B. J. Immunol. 2001, 166:6250-6256.
210. Vuong M.T., Hahn-Zoric M., Lundberg S., Gunnarsson I., van Kooten C., Wramner L., Seddighzadeh M., Fernstrom A., Hanson L.A., Do L.T., Jacobson S.H., Padyukov L. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy. Kidney Int. 2010, 78:1281-1287.
211. Wang R., Fu Y., Zhao Q., Pan L., Zhang W. Human Fcalpha/muR and pIgR distribute differently in intestinal tissues. Biochem. Biophys. Res. Commun. 2009, 381:148-152.
212. Watanabe A., Shimokawa T., Moriyama M., Komine F., Amaki S., Arakawa Y., Ra C. Genetic variants of the IgA Fc receptor (FcalphaR, CD89) promoter in chronic hepatitis C patients. Immunogenetics 2006, 58:937-946.
213. Weigel P.H., Yik J.H. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors. Biochim. Biophys. Acta 2002, 1572:341-363.
214. White K.D., Capra J.D. Targeting mucosal sites by polymeric immunoglobulin receptor-directed peptides. J. Exp. Med. 2002, 196:551-555.
215. Wilton J.M. Suppression by IgA of IgG-mediated phagocytosis by human polymorphonuclear leucocytes. Clin. Exp. Immunol. 1978, 34:423-428.
216. Wines B.D., Hulett M.D., Jamieson G.P., Trist H.M., Spratt J.M., Hogarth P.M. Identification of residues in the first domain of human Fc alpha receptor essential for interaction with IgA. J. Immunol. 1999, 162:2146-2153.
217. Wines B.D., Sardjono C.T., Trist H.H., Lay C.S., Hogarth P.M. The interaction of Fc alpha RI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. J. Immunol. 2001, 166:1781-1789.
218. Wines B.D., Trist H.M., Farrugia W., Ngo C., Trowsdale J., Areschoug T., Lindahl G., Fraser J.D., Ramsland P.A. A conserved host and pathogen recognition site on immunoglobulins: structural and functional aspects. Adv. Exp. Med. Biol. 2012, 946:87-112.
219. Wines B.D., Trist H.M., Monteiro R.C., van Kooten C., Hogarth P.M. Fc receptor gamma chain residues at the interface of the cytoplasmic and transmembrane domains affect association with FcalphaRI, surface expression, and function. J. Biol. Chem. 2004, 279:26339-26345.
220. Wines B.D., Trist H.M., Ramsland P.A., Hogarth P.M. A common site of the Fc receptor gamma subunit interacts with the unrelated immunoreceptors FcalphaRI and FcepsilonRI. J. Biol. Chem. 2006, 281:17108-17113.
221. Wines B.D., Willoughby N., Fraser J.D., Hogarth P.M. A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgA. J. Biol. Chem. 2006, 281:1389-1393.
222. Wolf H.M., Eibl M.M. The anti-inflammatory effect of an oral immunoglobulin (IgA-IgG) preparation and its possible relevance for the prevention of necrotizing enterocolitis. Acta Paediatr. Suppl. 1994, 396:37-40.
223. Wolf H.M., Fischer M.B., Puhringer H., Samstag A., Vogel E., Eibl M.M. Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6) in human monocytes. Blood 1994, 83:1278-1288.
224. Woof J.M., Burton D.R. Human antibody-Fc receptor interactions illuminated by crystal structures. Nat. Rev. Immunol. 2004, 4:89-99.
225. Wu J., Ji C., Xie F., Langefeld C.D., Qian K., Gibson A.W., Edberg J.C., Kimberly R.P. FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA. J. Immunol. 2007, 178:3973-3982.
226. Wu L.C. Immunoglobulin E receptor signaling and asthma. J. Biol. Chem. 2011, 286:32891-32897.
227. Xue J., Zhao Q., Zhu L., Zhang W. Deglycosylation of FcalphaR at N58 increases its binding to IgA. Glycobiology 2010, 20:905-915.
228. Yang X., Zhao Q., Zhu L., Zhang W. The three complementarity-determining region-like loops in the second extracellular domain of human Fc alpha/mu receptor contribute to its binding of IgA and IgM. Immunobiology 2012, 218:798-809.
229. Ye L., Zeng R., Bai Y., Roopenian D.C., Zhu X. Efficient mucosal vaccination mediated by the neonatal Fc receptor. Nat. Biotechnol. 2011, 29:158-163.
230. Yoo E.M., Trinh K.R., Lim H., Wims L.A., Morrison S.L. Characterization of IgA and IgM binding and internalization by surface-expressed human Fcalpha/mu receptor. Mol. Immunol. 2011, 48:1818-1826.
231. Zhang G., Young J.R., Tregaskes C.A., Sopp P., Howard C.J. Identification of a novel class of mammalian Fc gamma receptor. J. Immunol. 1995, 155:1534-1541.
232. Zhao J., Kuroki M., Shibaguchi H., Wang L., Huo Q., Takami N., Tanaka T., Kinugasa T. Recombinant human monoclonal igA antibody against CEA to recruit neutrophils to CEA-expressing cells. Oncol. Res. 2008, 17:217-222.
233. Zhu X., Meng G., Dickinson B.L., Li X., Mizoguchi E., Miao L., Wang Y., Robert C., Wu B., Smith P.D., Lencer W.I., Blumberg R.S. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J. Immunol. 2001, 166:3266-3276.